Pediatrix Medical Group, Inc. (MD)
NYSE: MD · IEX Real-Time Price · USD
10.03
+0.04 (0.40%)
Mar 28, 2024, 4:00 PM EDT - Market closed

Pediatrix Medical Group Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Year 2023202220212020201920182017201620152014 2013 - 1994
Net Income
-60.4166.34130.96-796.49-1,497.7268.63320.37324.91336.32317.28
Upgrade
Depreciation & Amortization
36.1735.6432.1528.4425.9324.3678.8689.2664.2345.99
Upgrade
Share-Based Compensation
12.3216.1318.9739.0433.4136.5928.783432.1331.72
Upgrade
Other Operating Activities
149.2448.84-105.34933.631,796-15.8783.37-4.4-63.9827.65
Upgrade
Operating Cash Flow
137.33166.9476.74204.62357.71313.71511.38443.78368.7422.64
Upgrade
Operating Cash Flow Growth
-17.74%117.55%-62.50%-42.80%14.03%-38.65%15.23%20.36%-12.76%4.25%
Upgrade
Capital Expenditures
-33.33-29.71-7.52-28.79-19.27-17.12-26.15-39.26-27.07-18.06
Upgrade
Acquisitions
-6.67-28.17-29.93-2.23-46.98-65.37-531.23-762.3-818.9-479.39
Upgrade
Change in Investments
-8.99-0.46-18.56-28.4116-2.17-2.31-19.65-2.02-6.15
Upgrade
Other Investing Activities
0.811.382.93874.94152.7-58.11-16.92---
Upgrade
Investing Cash Flow
-48.18-56.95-53.07815.51102.46-142.77-576.61-821.22-848-503.6
Upgrade
Share Issuance / Repurchase
3.99-83.122.13-1.48-134.02-285.9-46.92-39.81-214.92-445.55
Upgrade
Debt Issued / Paid
-19.12-413.79-762.66-1.67-248.69121.91141.82427.87699.14536.56
Upgrade
Other Financing Activities
-10.599.350.41-1-10.35-6.62-5.16-6.5-1.276.75
Upgrade
Financing Cash Flow
-25.72-487.55-760.12-4.16-393.07-170.6189.74381.57482.9497.75
Upgrade
Net Cash Flow
63.43-377.57-736.451,01667.10.3324.54.133.6416.79
Upgrade
Free Cash Flow
104137.2369.22175.83338.44296.59485.23404.51341.63404.58
Upgrade
Free Cash Flow Growth
-24.22%98.27%-60.64%-48.05%14.11%-38.88%19.95%18.41%-15.56%3.81%
Upgrade
Free Cash Flow Margin
5.21%6.96%3.62%10.14%19.02%17.21%14.91%12.71%12.29%16.59%
Upgrade
Free Cash Flow Per Share
1.261.640.822.114.053.255.254.383.674.10
Upgrade
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).